Cargando…

Molecular Subtypes Based on Cell Differentiation Trajectories in Head and Neck Squamous Cell Carcinoma: Differential Prognosis and Immunotherapeutic Responses

OBJECTIVE: Head and neck squamous cell carcinoma (HNSCC) is one of the most common and lethal malignant tumors. We aimed to investigate the HNSCC cell differentiation trajectories and the corresponding clinical relevance. METHODS: Based on HNSCC cell differentiation-related genes (HDRGs) identified...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Zhen-Dong, Liu, Zi-Zhen, Liu, Yan-Yi, Fu, Yong-Cheng, Lin, Lu-Lu, Hu, Chao, Gu, Hui-Yun, Wei, Ren-Xiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739483/ https://www.ncbi.nlm.nih.gov/pubmed/35003112 http://dx.doi.org/10.3389/fimmu.2021.791621

Ejemplares similares

Identification of Immune-Related LncRNA Pairs for Predicting Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma
por: Wang, Xueying, et al.
Publicado: (2021)

Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma
por: Bann, Darrin V., et al.
Publicado: (2016)

Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck
por: Xu, Qiang, et al.
Publicado: (2020)

Cell Differentiation Trajectory Predicts Prognosis and Immunotherapeutic Response in Clear Cell Renal Cell Carcinoma
por: Xu, Jin, et al.
Publicado: (2022)

Prognostic value of the immunohistochemical score based on four markers in head and neck squamous cell carcinoma
por: Xu, Qing-Qing, et al.
Publicado: (2023)

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma
por: Wang, Xinwen, et al.
Publicado: (2021)

Comprehensive Analysis of Myeloid Signature Genes in Head and Neck Squamous Cell Carcinoma to Predict the Prognosis and Immune Infiltration
por: Liu, Zhifeng, et al.
Publicado: (2021)

DCBLD1 Overexpression Is Associated With a Poor Prognosis in Head and Neck Squamous Cell Carcinoma
por: Fu, Ling-ling, et al.
Publicado: (2022)

The role of nanotherapy in head and neck squamous cell carcinoma by targeting tumor microenvironment
por: Zhang, Ye, et al.
Publicado: (2023)

High Abundance of Intratumoral γδ T Cells Favors a Better Prognosis in Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis
por: Lu, Huanzi, et al.
Publicado: (2020)

Spatial Profiles of Intratumoral PD-1(+) Helper T Cells Predict Prognosis in Head and Neck Squamous Cell Carcinoma
por: Yoshimura, Kanako, et al.
Publicado: (2021)

The Differential Impact of SRC Expression on the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma
por: Hermida-Prado, Francisco, et al.
Publicado: (2019)

Corrigendum: DCBLD1 Overexpression is associated with a poor prognosis in head and neck squamous cell carcinoma
por: Fu, Ling-ling, et al.
Publicado: (2022)

Identification and Validation of 17-lncRNA Related to Regulatory T Cell Heterogeneity as a Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Sun, Qi, et al.
Publicado: (2021)

Constrast-enhanced computed tomography radiomics predicts CD27 expression and clinical prognosis in head and neck squamous cell carcinoma
por: Wang, Fang, et al.
Publicado: (2022)

Identification of Immune Subtypes for Predicting the Prognosis of Patients in Head and Neck Squamous Cell Carcinoma
por: Sun, Jing, et al.
Publicado: (2021)

Analysis of immunotherapeutic response-related signatures in esophageal squamous-cell carcinoma
por: Zheng, Bohao, et al.
Publicado: (2023)

Prognosis-related molecular subtyping in head and neck squamous cell carcinoma patients based on glycolytic/cholesterogenic gene data
por: Zhou, Zekun, et al.
Publicado: (2023)

Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects
por: Gao, Lei, et al.
Publicado: (2022)

A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma
por: Li, Qilin, et al.
Publicado: (2022)

Efficacy and safety of pembrolizumab with preoperative neoadjuvant chemotherapy in patients with resectable locally advanced head and neck squamous cell carcinomas
por: Wang, Kai, et al.
Publicado: (2023)

Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report
por: Merhi, Maysaloun, et al.
Publicado: (2018)

Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness
por: Zhang, Pei, et al.
Publicado: (2021)

Cuproptosis-related gene subtypes predict prognosis in patients with head and neck squamous cell carcinoma
por: Wang, Chi, et al.
Publicado: (2023)

The prognostic impact of the immune signature in head and neck squamous cell carcinoma
por: Baysal, Hasan, et al.
Publicado: (2022)

Single-cell RNA sequencing reveals TCR(+) macrophages in HPV-related head and neck squamous cell carcinoma
por: Jiang, Yourong, et al.
Publicado: (2022)

A predictive model of immune infiltration and prognosis of head and neck squamous cell carcinoma based on cell adhesion-related genes: including molecular biological validation
por: Liu, Yuchen, et al.
Publicado: (2023)

The genes regulating sensitivity of tumor cells to T cell-mediated killing: could they be potential personalized immunotherapeutic targets in head and neck squamous cell carcinoma?
por: Hu, Shaonan, et al.
Publicado: (2023)

BASP1 is a prognostic biomarker associated with immunotherapeutic response in head and neck squamous cell carcinoma
por: Pan, Xue, et al.
Publicado: (2023)

The Common Costimulatory and Coinhibitory Signaling Molecules in Head and Neck Squamous Cell Carcinoma
por: Liao, Peng, et al.
Publicado: (2019)

TNF Patterns and Tumor Microenvironment Characterization in Head and Neck Squamous Cell Carcinoma
por: Long, Qian, et al.
Publicado: (2021)

CCTs as new biomarkers for the prognosis of head and neck squamous cancer
por: Dong, Yanbo, et al.
Publicado: (2020)

Differential expression profiling of head and neck squamous cell carcinoma (HNSCC)
por: Lemaire, F, et al.
Publicado: (2003)

Human papillomavirus infection can alter the level of tumour stemness and T cell infiltration in patients with head and neck squamous cell carcinoma
por: Meng, Lingzhang, et al.
Publicado: (2022)

Circadian Regulator-Mediated Molecular Subtypes Depict the Features of Tumor Microenvironment and Indicate Prognosis in Head and Neck Squamous Cell Carcinoma
por: Aye, Ling, et al.
Publicado: (2023)

Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma
por: Shen, Ao, et al.
Publicado: (2022)

The immunotherapeutic role of indoleamine 2,3‐dioxygenase in head and neck squamous cell carcinoma: A systematic review
por: Lin, Daniel J., et al.
Publicado: (2021)

Identification and Biological Validation of a Chemokine/Chemokine Receptor-Based Risk Model for Predicting Immunotherapeutic Response and Prognosis in Head and Neck Squamous Cell Carcinoma
por: Wang, Ye, et al.
Publicado: (2023)

T cell-mediated tumor killing patterns in head and neck squamous cell carcinoma identify novel molecular subtypes, with prognosis and therapeutic implications
por: Meng, Zilu, et al.
Publicado: (2023)

Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma
por: Bao, Jiantong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0enc3t0g6i4tlsg4i6ekgogi4b